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ABSTRACT 
Hepatic injury and its associated conditions have been reportedly shown to be managed through herbal remedies. In this study, 
investigation of the fresh leaf aqueous extract of Flacourtia indica (of the family of Salicaceae) as hypoglycemic, anti-anemic and 
hepatoprotective agent in albino wistar rats induced CCl4 hepatotocxicity was done. Fifteen rats of either sex, weighing 175-295g, 
divided into five groups (I-V) of three rats each, were used. Group-I is negative control, II-positive control and III –V test groups. 
Groups II-V were induced 200mg/Kg/bodyweight CCl4, for 3-days, for hepatic injury and anemia. Groups III-V were respectively 
treated orally with 400, 600 and 800 mg/Kg/bodyweight of fresh leaf aqueous extracts (FLAE) of Flacourtia indica, for 7-days. 
Activities of alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, concentrations of bilirubin, albumin, total 
protein, blood glucose and packed cell volume (PCV) and hemoglobin were assayed. Results after induction showed significant 
(p˂0.05) decrease in heamoglobin and PCV, significant (p˂0.05) increase in the liver function enzymes and blood glucose 
compared with results of liver function enzyme and blood glucose having significant (p˂0.05) decrease, and significant (p˂0.05) 
increase of PCV and hemoglobin after treatment with FLAE of Flacourtia indica. Body weight of rats induced CCl4 was found to 
increase with FLAE of Flacourtia indica treatment. It may be concluded that the potentials exhibited by FLAE of Flacourtia 
indica to manage hyperglycaemia, hepatic injury and anemia induced by CCl4 are associated with its antioxidant activity and the 
presence of phytochemicals, minerals and nutrients value. 
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INTRODUCTION 
Plants have been largely used in the quest of managing 
health challenges as alternative of nature’s providence. 
Traditional medicine practice is an age long practice 
common in developing countries
1
. Several bioactive 
compounds in plants are known with their antioxidant 
and scavenging abilities
2
. Phytochemicals are 
chemicals in plants with no nutritive value but highly 
effective in disease prevention and protection when 
consumed. Most of these bioactive plants’ compounds 
have been implicated in the treatment, management 
and prevention of ailments. Several studies have 
demonstrated the use of plants’ extracts as 
hepatoprotective and gluco-stabilizer in Albino wistar 
rats induced aluminium chloride hepatic toxicity
3
 and
4
 
reported various methods of extraction, isolation, 
identification and purification of bioactive compounds 
in plants. Flacourtia indica’s leaf, stem bark, fruits and 
root like other plants, is not exempted from these 
beneficial characteristics. These have been shown to 
possess biological, medicinal and pharmacological 
potentials in the prevention and treatment of hepatic 
disease
3
, cardiovascular diseases, cancer
5
, diabetes
6
, 
bacterial infection
1
, and other conditions like anemia 
hyperglycemia and hypercholesterolemia
7,8
. Various 
researchers have demonstrated that plants are rich 
sources of antioxidant vitamins such as vitamins A, C 
and E
4
, minerals such as Fe, Mg, Mn, N, P, Ca, Na and 
K
9
 and phytochemicals such as phenolics (tannins, 
flavonoids), carotenoids, anthocyanins, coumarin 
glycosides
1
. 
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The liver is an organ with multiple functions. It is 
involved in circulation of blood, plays major role in 
metabolic reactions, seen in conversion of excess blood 
glucose to glycogen, carries out detoxification by 
secretion of bile, involved in production of blood 
clotting factor by production of fibrinogen, heparin and 
prothrombin
10,11
.  
Hepatic diseases pose a universal concern to Humans 
and other animals, contributing a large cause of 
mortality and morbidity. These include fatty liver, 
cirrhosis; hepatitis (A, B, C, D and E), drug/chemical 
induced hepatic injury, hepatic cancer and alcohol 
induced hepatic injury
11
. Chemical/drug induced liver 
toxicity is reported to be the paramount cause of 
hepatotoxicity. This has been linked to life style, abuse 
and misuse of drug, occupational, laboratory and 
industrial exposure to substances and chemicals like 
carbon tetrachloride, aluminum chloride, alcohol etc 
10
. 
The mechanism through which carbon tetrachloride 
CCl4 and these other chemical substances exert liver 
damage is understood to be linked to production of 
reactive oxygen species. This result in lipid 
peroxidation of liver tissues as a consequence of the 
high put of free radicals generated which subdues the 
liver’s defense system, degenerating to inflammation, 
hepatic apoptosis, liver cirrhosis and fibrosis
12,13
.  
Anemia sets in due to lack of adequate and healthy red 
blood cells (RBC) and hemoglobin, the oxygen binding 
component of the blood. Anemia is a condition that is 
commonly affected by infants, child bearing age 
women/pregnant women, the young and the elderly
14
. 
Different types of anemia arise from their causes. 
Anemia is considered to be caused by abnormal RBC 
production (iron deficiency anemia, vitamin deficiency 
anemia, aplastic anemia thalasemia etc), destruction of 
red blood cell (sickle cell anemia, clotting disorder, 
hemolytic disease etc) and loss of blood through 
uncontrolled bleeding
15
. Anemia has been reported to 
be induced by several chemical substances such as 
AlCl3 and phenylhydrazine
14,16
, reported the prevalence 
of anemia among the elderly with value of hemoglobin 
Hb < 12g/dL in women and Hb <13g/dL in men.  
This study was carried out to evaluate the potential of 
fresh leaf aqueous extracts (FLAE) of Flacourtia 
indica as a hepatoprotective, anti-anemic and 
hypoglycemic agent in CCl4 induced hepatic injury in 
Albino wistar rats. 
 
MATERIALS AND METHODS 
Collection and Preparation of Plant Samples 
Fresh leaf materials of Flacourtia indica (Governor’s 
plum) were collected from around staff quarter of 
Caritas University, Amorji-Nike, Enugu state, Nigeria. 
The required plant leaf was authenticated and a 
voucher number of PSB/109-12.A was given by Mr. 
Okafor, C.U., a botanist in plant tissue culture and 
biotechnology department, Faculty of Biological 
Science, University of Nigeria, Nsukka. The aqueous 
plant extracts were prepared selecting fresh leaf aerial 
part, weighed and squeezed in a bowl of containing 
water and filtered and filtrate was used for oral 
treatment. The volumes of the extracts to be 
administered were calculated according to the body 
weight of the rats using the formula: 
Volume to be administered  ml 
=
weight of rats  kg x Concentration Dose (mg/kg) 
Concentration Dose (mg/kg)
 
Collection and Preparation of Blood Sample 
Three milliliter (3mls) of blood was collected from the 
rats by capillary pressure insertion into the side of the 
eye using capillary tubes into a plain bottle, for the 
collection of serum used for biochemical assay (liver 
function test) and about 3mls collected in an EDTA 
sample bottle for hematological assay (PCV and 
hemoglobin). The samples in bottles were stored at 
room temperature.  
Study Animals 
Albino Wistar rats of 175-294g weight, of either sex 
were obtained from university of Nigeria Nsukka. 
Animals were housed at an ambient temperature and 
relative humidity in the animals’ house of department 
of Biochemistry, natural sciences, Caritas University, 
Amorji–Nike Enugu. The rats were allowed to 
acclimatize for one week prior to the experiment and 
had access to standardized pelletized finisher feed and 
clean water within the period of the acclimatization. 
The principle of laboratory animals’ care and ethical 
guidelines for investigation of experimental pain in 
conscious animals were followed respectively 
17, 18
.  
Design and Animal Grouping 
A total of fifteen (15) Wistar albino rats, divided into 
five groups (Groups I–V) of three rats each was used 
for this study.   
Group I: Negative control consist of 3 rats, no carbon 
tetrachloride CCl4 and FLAE of   Flacourtia indica 
were administered.  
Group II: Test control (positive control) consist 
of 3 rats, were administered orally with 
200mg/Kg/bodyweight CCl4 without FLAE of   
Flacourtia indica. 
Group III: Consist of 3 rats, administered orally 
with 200mg/Kg/bodyweight CCl4 and 400mg/kg/body 
weight FLAE of Flacourtia indica. 
Group IV: Consist of 3 rats, administered orally 
with 200mg/Kg/bodyweight CCl4 and 600mg/kg/body 
weight FLAE of Flacourtia indica. 
Group V: Consist of 3 rats, administered orally 
with 200mg/Kg/bodyweight CCl4 and 800mg/kg/body 
weight FLAE of   Flacourtia indica. 
At the end of induction (three days), blood sample was 
collected from each group for biochemical and 
hematological assays before treatment with FLAE of   
Flacourtia indica. After treatment with FLAE of   
Flacourtia indica for seven days, blood sample was 
also collected for biochemical and hematological 
assays. 
Induction of Liver Injury and Anemia 
Rats of groups II–V were induced with liver injury and 
anemia by single oral administration with 200mg/kg 
body weight of CCl4 respectively. A confirmatory test 
was carried out after induction of anemia by assaying 
the plasma hemoglobin percentage to show that the rats 
were anemic.  
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Liver Function Assay 
After collection of blood sample from rats, serum was 
collected by clot retraction. Serum ALT, AST, ALP, 
Albumin, Total protein and Bilirubin were assayed by 
the standard method as described by
19 
with the use of 
kits from Randox Laboratories Ltd, 55 Diamond Road, 
Crumlin, country Antrim, BT29 4QY, United 
Kingdom. 
Hematological Assay 
The Haemoglobin (Hb) and packed Cell Volume 
(PCV) values were determined by standard method as 
described by
20
 using hematocrite and Mindray 
Haematology Analyser (Mindray BC-2300, Guangzhou 
Shihai Medical Equipment Co., Ltd, China). 
Chemicals 
All chemicals used were pure and of analytical grade. 
Liver function enzymes assay reagents for 
Bilirubin(BIL), Alanine Aminotransferase (ALT), 
Aspartate Aminotransferase (AST), Albumin (ALB), 
Total Protein (TP) and Alkaline phosphatase (ALP) 
employed kits obtained from Randox Laboratories Ltd, 
55 Diamond Road, crumlin, country Antrim, BT29 
4QY, United Kingdom. Aluminium trichloride AlCl3 
was purchased from BDH Laboratories/Chemicals Ltd, 
Poole, England.   
Statistical Analysis 
Results were expressed as mean ± standard deviation 
and analyzed using one-way ANOVA (analysis of 
variance), p value (<0.05) was considered significant. 
A component of graph pad instat 3 software version 
3.05 and graphpad prism version 7.04 by graph pad 
Inc. was employed
21
.  
 
RESULTS  
Table 1 shows the liver function parameters of rats 
after induction with 200mg CCl4, for liver injury. There 
was an observed significant (p<0.05) increase in TP, 
ALB, BIL, ALP, ALT and AST of group I (negative 
control) compared to group II (positive control) and 
test groups (III, IV and V). 
Table 2 shows liver function assay of rats administered 
various doses (400mg/kg, 600mg/kg and 800mg/kg) of 
Fresh Leaf Aqueous Extract (FLAE) of Flacourtia 
indica for seven (7) days. A significant (p<0.05) 
increase was observed in all parameters assayed in the 
test groups (III, IV and V) compared to group II (test 
control) and group I (negative control).  
The packed cell volume (PCV) and hemoglobin of rats 
after induction with CCl4 and after treatment with Fresh 
Leaf Aqueous Extract (FLAE) of Flacourtia indica for 
seven (7) days is shown in table 3. The result shows a 
significant (p<0.05) increase in PCV and hemoglobin 
after treatment with FLAE of Flacourtia indica 
compared to after induction with CCl4. 
Blood glucose concentration of rats after induction 
with CCl4 and after Treatment with Fresh Leaf 
Aqueous Extract (FLAE) of Flacourtia indica for 
seven (7) days is shown in Table 4. After FLAE 
Flacourtia indica was administered, to test groups (III, 
IV and V), the blood glucose concentrations of test 
groups were observed to decrease significantly 
(p<0.05) compared to after induction with CCl4 and 
thus acerbating induced hypoglycemia. 
The body weights of rats are shown in Table 5 at 
acclimatization, at induction with CCl4 and at treatment 
with FLAE of Flacourtia indica. There was significant 
(p<0.05) decrease in body weight of at induction and 
significant increase in body weight after treatment with 
FLAE of Flacourtia indica, which may be indicative of 
recovery from anemia.     
The results show significantly higher (P < 0.05) level 
of group II rats (positive control) compared to group I 
(negative control), group III (400mg/kg FLF indica), 
group IV (600mg/kg FLF.indica) and group V 
(800mg/kg FLF indica). There were significant 
differences (P < 0.05) observed in comparing group I 
with groups III, IV and V. Also, significant differences 
(P < 0.05) were observed when the treated groups (III, 
IV and V) are compared with one another, not 
necessary in a dose dependent manner.     
As shown in Figure 1, the results of induction with 
200mg/kg CCl4 reveal significantly higher (P < 0.05) 
levels of groups II (positive control), III, IV and V 
compared to group I (negative control). 
Results in Figure 4 also reveal significantly higher (P < 
0.05) differences in the concentration of Alkaline 
Phosphatase (ALP) when group I (negative control) is 
compared with group III (400mg/kg FLF.indica), 
group IV (600mg/kg FLF indica) and group V 
(800mg/kg FLF. indica). When the concentrations of 
ALP in groups III, IV and V were compared with one 
another, significant differences (P < 0.05) were 
observed in a dose dependent pattern.  
 
DISCUSSION 
Carbon tetrachloride (CCl4) induced hepatic injury is 
shown in Table 1 and (Figure 1 and Figure 3). The rise 
in the level of ALT, AST, ALB, ALP, BIL and TP of 
groups II, III, IV and V when compared to group I 
indicates a CCl4 induced liver damage. This is 
consistence with
22
, who reported the use of 1.5ml/kg 
body weight of CCl4 orally administered to rats to 
induce liver damage. These liver function enzymes are 
found to be located in the cytosol of the liver cell and 
thus, are easily released into the serum after cellular 
liver damage
23
. The mechanism of action involved in 
CCl4 hepatic injury is understood to be linked to the 
liver phase II detoxification action. The liver, in the 
process of detoxification transforms Carbon 
tetrachloride (CCl4) in the presence and action of 
cytochrome P450 enzyme component to produce peroxy 
trichloromethyl and trichloromethyl free radicals
13
. 
These free radicals results in lipid peroxidation by 
reacting covalently with biomolecules (proteins, 
nucleic acids, lipids etc) in the presence of oxygen. 
Thus the liver becomes damaged and obviously its cell 
membrane becomes degenerate, permeable and licks 
out its cellular contents of AST, ALT, TP, ALP, BIL 
and ALB
24
. After induction with CCl4, the level of 
blood glucose was raised (Table 4), hemoglobin and 
PCV (Table 3) levels were decreased. This could 
suggest that CCl4 induced anemia was possible owing 
from the destruction of red blood cells and shortage of 
circulating mineral iron and vitamins
15
. Hyperglycemia 
induced by CCl4 could be due pancreatic injury caused 
by generation of free radical, cell membrane lipid 
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peroxidation and subsequent destruction of pancreatic 
β- islet cells3. 
Administration of CCl4 induced rats with FLAE of 
Flacourtia indica shows reduction in the 
concentrations of liver function enzymes (TP, AST, 
ALT, ALP, and BIL) in the serum and blood glucose 
(Table 2 and  Table 4 and Figure 2 and Figure 4). 
Similarly, after treatment with FLAE of Flacourtia 
indica the levels of ALB, Hb and PCV increased as 
shown in Table 2 and Table 4. The reduced serum 
levels of the liver function enzymes indicate the 
recuperative, regenerative and healing effect of FLAE 
of Flacourtia indica on the hepatic cells. This is in 
support of
3
, who reported that treatment with 
Flacourtia indica’s ethanol extract stem bark with 500 
mg/kg and 700 mg/kg in rats liver revealed 
regeneration of hepatocytes and absence of 
inflammation. It appears FLAE of Flacourtia indica 
exert its effects by antioxidant and free radical 
scavenging strength by furnishing the body with 
antioxidants phytochemicals (tannins, flavonoids, 
carotenoids, anthacyanins), minerals (Fe, Mg, Mn, Na, 
K) and vitamins (A, C and E)
4,22
.  
Blood glucose was found to decrease with treatment 
with FLAE of Flacourtia indica. This could be 
associated with its antioxidant ability of increasing 
insulin production and regeneration of the β- islet cells 
of pancreas that was ones destroyed by CCl4 
induction
22
,
7
 buttresses that the presence of minerals in 
plants enhance effective function of the glycolytic 
pathway enzymes for the breakdown of glucose. That 
minerals enhances the phosphorylation conversion 
reaction of glucose to glucose 6-phosphate by the 
action of the enzyme hexokinase or glucokinase and 
phosphorylation of fructose 6-phosphate by the action 
of phosphofructose kinase (PFK) to fructose 1, 6–
bisphosphate
7
.  
The hematological indices of PCV and Hb after 
treating the CCl4 anemia induced rats with FLAE of 
Flacourtia indica revealed increased levels of PCV and 
Hb. The anti-anaemic and haem regenerating effects of 
FLAE of Flacourtia indica as depicted by the results of 
this study, could be associated to some extent on the 
antioxidants phytochemical and mineral elements it 
contains
14,9
. Antioxidant phytochemicals such as 
saponins, flavonoids and alkaloids have been reported 
for their ant-anemic abilities, prevent thrombosis and 
aggregation of platelet and promote enhanced blood 
circulation
25,26
. Thus, FLAE of Flacourtia indica was 
able to increase the levels of PCV and Hb because of 
these phytochemicals and mineral elements contents. 
This action could be made possible by its enhanced 
removal of the toxic effects caused by CCl4 and 
creating flourishing iron utilization for the production 
of heme and subsequent release of new red blood 
cells
14
. FLAE of Flacourtia indica could have exert its 
effects in the improved production of Hb and PCV by 
enhancing the production of erythropoietin in the bone 
marrow stem cells and subsequent synthesis of new 
blood cells
27
. In addition, there was an observed 
reduced body weight of anemic rats (CCl4 induced 
groups) when compared to the groups treated with 
FLAE of Flacourtia indica (Table 5). This reduction in 
body weight of anemic rats and increase or weight gain 
in the treated group with FLAE of Flacourtia indica is 
consistent with the report of
14
. The association of 
weight loss with anemia is not very clear. However, it 
appears to be related to defect in carbohydrates 
digestion in the small intestine of anemic rats due to 
insufficient amount of the enzyme, disaccharidases, 
thus leading to undigested carbohydrates
28
.  
 
CONCLUSION  
The use of fresh leaf aqueous extract of Flacourtia 
indica in this study reveals that the plant possesses 
anti-anemia, hypoglycemic and hepato-healing 
potentials. This is obviously seen in the reduced levels 
of blood glucose, liver function assay, and in the raised 
levels of the hematological parameters, coupled with 
weight gain after treating CCl4 induced groups with 
FLAE of Flacourtia indica.  
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Table 1: Liver function test of Rats after Induction with 200mg/kg CCl4 body weight of rats   
Group TP(g/dl) ALB(g/dl) BIL(mg/dl) ALP(U/L) ALT(U/L)  AST(U/L) 
I 10.70±7.11
abcd
 4.58±3.02
abcd
 12.88±0.77
abcd
 1381.67±71.12
abcd
 38.7±5.33
abcd
 41.00±6.44
abcd
 
II 7.49±5.48
a
 6.56±7.13
a
 9.49±1.02
a
 2612.00±36.49
a
 77.04±2.34
a
 76.8±4.33
a
 
III 2.58±0.95
b
 3.72±0.23
b
 3.38±0.59
b
 1453.14±419.60
b
 68.00±24.37
b
 75.00±10.36
b
 
IV 3.26±0.49
c
 3.29±0.62
c
 4.09±0.70
c
 1927.81±99.46
c
 79.50±20.51
c
 78.00±15.56
c
 
V 4.23±1.78
d
 3.75±0.04
d
 4.11±1.39
d
 1712.58±212.73
d
 79.50±20.51
d
 71.50±6.36
d
 
Results are mean ± standard deviation, Values in the same column bearing similar superscripts are significantly different at P<0.05. (n=3). Key: I: 
Negative Control Group, II: positive control and III, IV and V: Test groups. TP: Total Protein, ALB: Albumin, BIL: Bilirubin, ALP: Alkaline 
Phosphatase, ALT: Alanine Transaminase, AST: Aspartate Transaminase.  
 
 
 
 
Table 2: Liver function assay of Rats after Treatment with 400, 600 and 800mg/kg/body weight of Fresh Leaf 
Aqueous Extract (FLAE) of Flacourtia indica 
Group TP(g/dl) ALB(g/dl) BIL(mg/dl) ALP(U/L) ALT(U/L)  AST(U/L) 
I 10.07±10.82
abc
 4.73±1.22
a
 8.98±1.01
ab
 1701.01±173.23
abc
 34.01±7.33
abc
 35.02±7.24
abc
 
II 6.98±7.63
a
 4.52±3.11 9.19±0.12
a
 2034.01±84.12
a
 67.00±2.08
a
 72.19±7.12
a
 
III 2.25±1.88
b
 2.34±0.97
a
 1.54±0.90 1003.85±134.52
b
 14.33±9.01
b
 59.50±0.71
b
 
IV 2.75±0.45
c
 1.38±0.58 2.15±2.14
b
 1565.34±550.95
c
 8.33±4.04
c
 40.33±2.52
c
 
V   2.26±0.89 0.46±0.11 0.51±0.33 992.22±68.31 15.67±4.04 48.33±9.87 
Results are mean ± standard deviation, Values in the same column bearing similar superscripts are significantly different at P<0.05. (n=3). Key: I: 
Negative Control Group, II: positive control and III, IV and V: Test groups, FLAE: Fresh Leaf Aqueous Extract, TP: Total Protein, ALB: Albumin, 
BIL: Bilirubin, ALP: Alkaline Phosphatase, ALT: Alanine Transaminase, AST: Aspartate Transaminase. 
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Table 3: Packed Cell Volume and Hemoglobin of rats after induction with CCl4 and after treatment with 
FLAE of Flacourtia indica 
  Group                After Induction    After Treatment 
 PCV Haemoglobin PCV Haemoglobin 
I 27.36±0.69
a
 10.00±4.56
u
 39.89±2.09
a
 16.03±2.05
u
 
II 34.54±7.15
b
 10.78±2.84
v
 49.87±15.09
b
 20.67±8.15
v
 
III 31.67±2.89
c
 10.56±0.96
w
 50.50±9.19
c
 16.84±3.06
w
 
IV 43.00±4.58
d
 14.00±2.00
x
 41.00±7.55
d
 13.67±2.52
x
 
V 36.50±4.95
e
 12.89±1.17
y
 45.33±4.16
e
 15.11±1.39
y
 
Results are mean ± standard deviation, Values in the same row bearing similar superscripts are significantly different at P<0.05. (n=3). Key: I: 
Negative Control Group, II: positive control and III, IV and V: Test groups, FLAE: Fresh Leaf Aqueous Extract. 
 
 
 
Table 4: Blood Glucose Concentration (mg/dl) of Rats after Induction with CCl4 and after Treatment with 
FLAE of Flacourtia indica  
Group After Induction After Treatment 
I 100.39±1.66
a
 89.88±25.71
a
 
II 88.26±1.19
b
 99.93±2.76
b
 
III 102.33±1.52
c
 95.00±5.29
c
 
IV 93.33±4.16
d
 80.00±12.29
d
 
V 82.67±15.37
e
 81.00±11.14
e
 
Results are mean ± standard deviation, Values in the same row bearing similar superscripts are significantly different at P<0.05. (n=3). Key: I: 
Negative Control Group, II: positive control and III, IV and V: Test groups, FLAE: Fresh Leaf Aqueous Extract. 
 
 
 
 
Table 5: Body Weight of rats before induction with CCl4, after induction with CCl4 and after treatment with 
FLAE of Flacourtia indica 
Group At 
acclimatization 
At induction 
with CCl4  
Treatment with FLAE 
of Flacourtia indica 
I 184.49±11.55
a
 218.21±7.70
a
 206.45±16.05
a
 
II 179.10±13.13
b
 221.15±14.42 207.55±6.16
b
 
III 222.48±13.93
c
 187.76±28.90
c
 235.10±34.22
c
 
IV 246.63±48.53
d
 227.95±41.98
d
 241.27±63.52
d
 
V 227.20±45.07
e
 219.63±39.17
e
 274.43±38.20
e
 
Results are mean ± standard deviation, Values in the same row bearing similar superscripts are significantly different at P<0.05. (n=3). Key: I: 
Negative Control Group, II: positive control and III, IV and V: Test groups, FLAE: Fresh Leaf Aqueous Extract. 
 
 
 
 
 
 
Figure 1: Liver function test after induction with 200 mg/kg body weight CCl4 
Letters a and b indicates significant difference (P < 0.05) when group I was compared with groups II, III, IV and V, respectively after CCl4 
induction of liver damage to rats in these groups. Graphs with same letters are not significantly (P < 0.05) different. 
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Figure 2: Liver function Assay for CCl4 induced rats treated with fresh leaf aqueous extract of Flacourtia 
indica  
FLF.indica═ fresh leaf of Flacourtia indica. Letters a, b, c, d and e indicates significant difference (P < 0.05) when group II was compared with 
groups I, III, IV and V, respectively for 400mg/kg, 600mg/kg and 800mg/kg FLAE Flacourtia indica treated groups.  
 
 
 
Figure 3: Alkaline phosphatase level of CCl4 induced rat’s liver damage 
Letters a, b, c, d and e indicates significant difference (P < 0.05) when group I was compared with groups II, III, IV and V, respectively after CCl4 
induced liver toxicity.  
 
 
 
Figure 4: Alkaline phosphatase for CCl4 induced rats treated with fresh leaf aqueous extract of Flacourtia 
indica 
FLF. indica═ fresh leaf of Flacourtia indica. Letters a, b, c, d and e indicates significant difference (P < 0.05) when group II was compared with 
groups I, III, IV and V, respectively for 400mg/kg, 600mg/kg and 800mg/kg Flacourtia indica treated groups.  
 
 
 
 
 
